Skip to main content
KURA
NASDAQ Life Sciences

Kura Oncology's Ziftomenib Combo Shows 94% 12-Month OS in Newly Diagnosed AML

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$8.83
Mkt Cap
$770.562M
52W Low
$5.45
52W High
$12.49
52W Position info
62% above low
Off High info
29% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

KURA sits 62% above its 52-week low of $5.45.

Summary

Kura Oncology announced compelling long-term Phase 1/2 results for its drug ziftomenib combined with 7+3 chemotherapy in newly diagnosed AML. The data showed a 94% 12-month overall survival rate and 96% complete remission rate in NPM1-m AML patients, significantly outperforming historical standard-of-care benchmarks. While ziftomenib (KOMZIFTI) is already approved for relapsed/refractory AML, these results support its potential expansion into the newly diagnosed setting, which would be a major market opportunity. The strong data bolsters the ongoing Phase 3 registrational study. Kura will host an investor event tomorrow, June 12, to discuss these findings.

At the time of this announcement, KURA was trading at $8.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $770.6M. The 52-week trading range was $5.45 to $12.49. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KURA - Latest Insights

KURA
Nov 10, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.29
Real-time Price: $7.74 info
Change: +$0.450 (+6%) info
Market Cap: $713.897M info
KURA
Nov 10, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.20
Real-time Price: $7.74 info
Change: +$0.540 (+8%) info
Market Cap: $713.897M info
KURA
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.45
Real-time Price: $7.74 info
Change: +$0.290 (+4%) info
Market Cap: $713.897M info
KURA
Nov 10, 2026, 4:02 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.45
Real-time Price: $7.74 info
Change: +$0.290 (+4%) info
Market Cap: $713.897M info
KURA
Sep 29, 2026, 5:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.70
Real-time Price: $7.74 info
Change: -$2.96 (-28%) info
Market Cap: $713.897M info